CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention Cellular origin and developmental program of coronary angiogenesis Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis Effect of low-density lipoprotein cholesterol on the geometry of coronary bifurcation lesions and clinical outcomes of coronary interventions in the J-REVERSE registry Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society Database Coronary Microcirculation in Ischemic Heart Disease Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials Machine Learning Using CT-FFR Predicts Proximal Atherosclerotic Plaque Formation Associated With LAD Myocardial Bridging

Review Article2016 Mar;18(3):19.

JOURNAL:Curr Treat Options Cardiovasc Med. Article Link

Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention

Li J, Patel SM, Parikh SA et al. Keywords: hemodynamic support; percutaneous coronary intervention; unprotected left main disease

ABSTRACT


Although the incidence of leftmain (LM) coronary artery disease is relatively low in patients undergoing routine angiography, it is a common presentation in patients with acute coronary syndromes. With the current interventional tools and techniques, percutaneous intervention for LM disease has become a viable alternative to the traditional coronary artery bypass grafting. Factors that contribute to the success and appropriateness of percutaneous intervention for LM disease include coronary anatomy and patient-specific factors such as left ventricular function. Multiple considerations should be taken into account prior to intervention, including hemodynamic support if necessary, intravascular imaging to guide therapy, and stent technique. This review provides an overview of the current body of literature to support the use of percutaneous intervention in LM disease and serves as guideline for the interventionalist approaching LM revascularization.